A phase I study to determine the pharmacokinetics and urinary excretion of belinostat and metabolites in patients with advanced solid tumors

被引：0
|
作者：
Hanna Bailey
Jordan P. McPherson
Erin B. Bailey
Theresa L. Werner
Sumati Gupta
Julia Batten
Guru Reddy
Gajanan Bhat
Sunil Sharma
Neeraj Agarwal
机构：
[1] The University of Utah,Huntsman Cancer Institute
[2] Spectrum Pharmaceuticals,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2016年 / 78卷
关键词：
Belinostat; PXD101; HDAC inhibitor; Pharmacokinetics; Metabolites; Elimination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1059 / 1071
页数：12
相关论文
共 50 条
  • [31] Pharmacokinetics and excretion of 14C-omacetaxine in patients with advanced solid tumors
    Cynthia M. Nijenhuis
    Edward Hellriegel
    Jos H. Beijnen
    Diane Hershock
    Alwin D. R. Huitema
    Luc Lucas
    Marja Mergui-Roelvink
    Mihaela Munteanu
    Laura Rabinovich-Guilatt
    Philmore Robertson
    Hilde Rosing
    Ofer Spiegelstein
    Jan H. M. Schellens
    Investigational New Drugs, 2016, 34 : 565 - 574
  • [32] Pharmacokinetics and excretion of 14C-omacetaxine in patients with advanced solid tumors
    Nijenhuis, Cynthia M.
    Hellriegel, Edward
    Beijnen, Jos H.
    Hershock, Diane
    Huitema, Alwin D. R.
    Lucas, Luc
    Mergui-Roelvink, Marja
    Munteanu, Mihaela
    Rabinovich-Guilatt, Laura
    Robertson, Philmore, Jr.
    Rosing, Hilde
    Spiegelstein, Ofer
    Schellens, Jan H. M.
    INVESTIGATIONAL NEW DRUGS, 2016, 34 (05) : 565 - 574
  • [33] Metabolism, Excretion, and Pharmacokinetics of Oral Brivanib in Patients with Advanced or Metastatic Solid Tumors
    Mekhail, Tarek
    Masson, Eric
    Fischer, Bruce S.
    Gong, Jiachang
    Iyer, Ramaswamy
    Gan, Jinping
    Pursley, Janice
    Patricia, Daniel
    Williams, Daphne
    Ganapathi, Ram
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (11) : 1962 - 1966
  • [34] Pharmacokinetics, metabolism, and routes of excretion of intravenous irofulven in patients with advanced solid tumors
    Paci, Angelo
    Rezai, Keyvan
    Deroussent, Alain
    De Valeriola, Dominique
    Re, Micheline
    Weill, Sophie
    Cvitkovic, Esteban
    Kahatt, Carmen
    Shah, Ajit
    Waters, Stephen
    Weems, Gary
    Vassal, Gilles
    Lokiec, Francois
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (11) : 1918 - 1926
  • [35] A phase 1 study of belinostat (PXD101) in combination with bortezomib in patients with advanced solid tumors and lymphoma
    O'Bryant, Cindy L.
    Leong, Stephen
    Camidge, D. Ross
    Gore, Lia
    Diab, Sami
    Gustafson, Dan L.
    Call, Justin
    Spratlin, Jennifer
    Zwiebel, James A.
    Eckhardt, S. Gail
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3384S - 3384S
  • [36] A phase 1 study of belinostat (PXD101) in combination with bortezomib in patients with advanced solid tumors or lymphoma
    Nallapareddy, Sujatha
    Leong, Stephen
    Camidge, Ross
    Gore, Lia
    Diab, Sami
    Messersmith, Wells
    Lewis, Karl
    Weekes, Colin
    Gustafson, Daniel
    Jimeno, Antonio
    Zwiebel, James
    -Delgado, Igor Espinoza
    Eckhardt, Gail
    O'Bryant, Cindy
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [37] A phase I study of bortezomib and temozolomide in patients with advanced solid tumors
    Portnow, J.
    Frankel, P.
    Koehler, S.
    Twardowski, P.
    Shibata, S.
    Martel, C.
    Morgan, R.
    Cristea, M.
    Chow, W.
    Lim, D.
    Chung, V.
    Reckamp, K.
    Leong, L.
    Synold, T. W.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (02) : 505 - 514
  • [38] A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors
    Haddad, Tufia
    Qin, Rui
    Lupu, Ruth
    Satele, Daniel
    Eadens, Matthew
    Goetz, Matthew P.
    Erlichman, Charles
    Molina, Julian
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (06) : 1221 - 1227
  • [39] A phase I study of oral ixabepilone in patients with advanced solid tumors
    Deeken, John F.
    Marshall, John L.
    Pishvaian, Michael J.
    Hwang, Jimmy
    Ahlers, Christoph M.
    Clemens, Pamela L.
    Parker, Susan M.
    Iacono, Lisa
    LoRusso, Patricia M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (05) : 1071 - 1078
  • [40] A phase i study of ixazomib and erlotinib in patients with advanced solid tumors
    Kato, Shumei
    Adashek, Jacob J.
    Subbiah, Vivek
    Fu, Siqing
    Sun, Mianen
    Nguyen, Ly
    Brown, Elsa J.
    Yap, Timothy A.
    Karp, Daniel D.
    Piha-Paul, Sarina A.
    Hong, David S.
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (01) : 99 - 105
12345